| Pharmaceutical active ingredients: |
| Anagrelide Hydrochloride |
| Available forms, composition and doses of Xagrid: |
| Capsules; Oral; Anagrelide Hydrochloride 0.5 mg |
| Xagrid medical category: |
| Human:Antineoplastic agentsMiscellaneous therapeutic agentsPlatelet-reducing agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01XX35 - Anagrelide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| ShireOpopharma |
| Related documents and information about Xagrid: |
| Xagrid prescribing information (PDF) |